Skip to main content
. 2021 Jun 10;12(2):107–116. doi: 10.4103/jcvjs.jcvjs_211_20

Table 3.

Tumor entities included in the study

Etiology Subtype Patients Total patients, n (%)
Sarcoma Giant cell tumor 114 263 (45.8)
Osteosarcoma 64
Hemangiopericytoma 24
Chondrosarcoma 22
Desmoplastic fibroma 13
Ewing sarcoma 9
Undifferentiated sarcoma 5
Synovial sarcoma 3
Pleomorphic sarcoma 2
Angiosarcoma 1
Desmoid 1
Fibrosarcoma 1
Leiomyosarcoma 1
Malignant peripheral nerve sheath tumor 1
Neurofibrosarcoma 1
Paget sarcoma 1
Metastasis Renal 44 180 (30.9)
Thyroid 34
Breast 26
Paraganglioma 16
Lung (not further specified) 14
Sarcoma 13
Adeno carcinoma (not further specified) 7
Prostate 5
Squamous cell (not further specified) 4
Germ cell tumor 3
Hepatocellular 2
Rectum 2
Unknown 2
Adrenal 1
Cholangiocellular 1
Colon 1
Endometrium 1
Laryngeal 1
Malignant schwannoma 1
Maxilla 1
Parotid 1
Testicular (not further specified) 1
Chordoma 62 (10.6)
Plasmocytoma 29 (5)
Osteoblastoma 22 (3.8)
Hemangioma 14 (2.4)
Aneurysmal bone cyst 3 (0.5)
Primary invading lung tumor 1 (0.2)
Neurofibroma 1 (0.2)